跳至主要内容
临床试验/NCT04952285
NCT04952285已完成不适用

The Efficacy and Safety of the Loading Dose of Tranexamic Acid in Scoliosis Surgery During Perioperative

Second Affiliated Hospital, School of Medicine, Zhejiang University0 个研究点目标入组 207 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
207
主要终点
Intraoperative blood loss

研究概览

简要总结

This study intends to make full use of the advantage of spinal orthopedic surgery in our medical center.Analyze the blood loss and blood coagulation function and the influence of safety of load dose tranexamic acid (TXA) in scoliosis surgery during perioperative.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • age:18-60 years old
  • American Society of Anesthesiologists (ASA):I-II
  • The spinal orthopedic undergoing elective surgery

排除标准

  • Severe cardiopulmonary dysfunction
  • Blood coagulation dysfunction
  • Disorders of liver and kidney function
  • Tranexamic acid allergies
  • The history of pulmonary embolism and venous thrombosis of lower limbs
  • Anticoagulant drugs and nonsteroidal anti-inflammatory drugs in 7 days

结局指标

主要结局

Intraoperative blood loss

时间窗: At the end of the surgery

Intraoperative blood loss

Incision drainage Incision drainage Incision drainage after surgery

时间窗: 24 hours after surgery

Incision drainage after surgery

次要结局

  • APTT(Within 1 week before surgery;1 day after surgery)
  • Autologous blood doping(At the end of the surgery)
  • red blood cell transfusion(At the end of the surgery)
  • Plasma infusion(At the end of the surgery)
  • HB(Within 1 week before surgery;1 day after surgery)
  • WBC(Within 1 week before surgery;1 day after surgery)
  • PTL(Within 1 week before surgery;1 day after surgery)
  • PT(Within 1 week before surgery;1 day after surgery)
  • INR(Within 1 week before surgery;1 day after surgery)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

相似试验

The Efficacy and Safety of the Loading Dose of... | 临床试验